Abstract Despite the advances in medical and device therapies for heart failure (HF), sudden cardiac death (SCD) remains a tremendous global burden patients with HF. Among risk factors SCD, HF has greatest impact. Previous studies focusing on systolic dysfunction have found several predictive associated leading to subsequent development of strategies primary prevention, like placement implantab...

Many emerging technologies are associated with 'risk'. While the concept of risk is protean, it is usually conceived of as the potential of something damaging or harmful happening. Thus, risks are a primary target of many regulatory regimes. In this article, after articulating an understanding of risk, we assess the European medical devices regulatory regime from a risk perspective, focusing on...

drilling operations are exposed to a variety of hazards, some of which may be location and activity dependent and each could pose different risk from different paths.  drilling operation may be vulnerable to hurricanes in one region and be exposed to geohazards in another. however, there are other hazards, (e.g. corrosion, age degradation, poor maintenance), which equally affects every rig. ide...

Abstract Background Totally implantable central venous access devices (ports) have been available for over 10 years, but have not been achieved widespread use in pediatric oncology patients. Ports facilitate the administration of chemotherapy in children with cancer. Materials and Methods In this study, early complications of implantable central venous access devices in children with diff...

The implantable cardioverter-defibrillator lead has undergone numerous design and manufacturing changes over the last 25 years aimed at improving patient care and outcomes. It is widely accepted that implantable cardioverterdefibrillator leads, similar to pacemaker leads, have a finite life. The design of an implantable cardioverter-defibrillator lead is more complex than that of a pacemaker le...

The implantable cardioverter defibrillator has achieved increasing acceptance in paediatric cardiologic practice. Concurrent with technological advances which have made the devices more versatile, easier to implant and to program, there has been a fundamental breakthrough in our understanding of genetic and inherited arrhythmia syndromes in the last decade. This in turn has led to investigation...

The computer security community has recently begun research on the security and privacy issues associated with implantable medical devices and identified both existing flaws and new techniques to improve future devices. This paper surveys some of the recent work from the security community and highlights three of the major factors affecting security and privacy solutions for implantable medical...

BACKGROUND Cardiac device infection (CDI) is a serious complication of cardiovascular implantable electronic device (CIED) implantations. Many risk factors have been identified, but several are still uncertain. This study aimed to identify and evaluate the risk factors. Moreover, an infection control protocol (ICP) was carried out, and its efficacy in reducing CDIs was investigated. MATERIAL AN...

Introduction Subcutaneous implantable cardioverter-defibrillators (S-ICD) provide an alternative to traditional transvenous implantable cardioverter-defibrillators (TV-ICD) and avoid complications associated with intravascular access and leads. They are highly effective in detecting and treating ventricular arrhythmias, with comparable inappropriate shock rates. Use of S-ICD is anticipated to i...

The most common presentation of arrhythmogenic right ventricular cardiomyopathy (ARVC) is palpitations or ventricular tachycardia (VT) of left bundle branch morphology in a young or middle-aged individual. The 12-lead electrocardiogram may be normal or have T-wave inversion beyond V(1) in an otherwise healthy person who is suspected of having ARVC. The most frequent imaging abnormalities are an...